Overview
Mandira Ray is a Hematologist Oncology specialist and a Hematologist in Burlington, Massachusetts. Dr. Ray is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Marginal Zone Lymphoma (MZL), and Opioid Induced Constipation. Dr. Ray is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Wall St, Burlington, MA 01803
90 Libbey Industrial Pkwy, Suite 201, Weymouth, MA 02189
2 Technology Park Dr, Suite A, Bourne, MA 02532
1250 Hancock St, Quincy, MA 02169
165 Dartmouth St, Boston, MA 02116
21 Bristol Dr, South Easton, MA 02375
133 Brookline Ave, Boston, MA 02215
40 Holland St, Somerville, MA 02144
1 Lyons St, Dedham, MA 02026
291 Independence Dr, Chestnut Hill, MA 02467
100 2nd Ave, Needham, MA 02494
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Bradley Mcgregor is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Mcgregor is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Muscle Invasive Bladder Cancer, Tissue Biopsy, and Nephrectomy. Dr. Mcgregor is currently accepting new patients.
The General Hospital Corporation
Marc Michaelson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Michaelson is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Orchiectomy, and Nephrectomy. Dr. Michaelson is currently accepting new patients.
The General Hospital Corporation
Richard Lee is an Oncologist and a Hematologist Oncology provider in Waltham, Massachusetts. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy. Dr. Lee is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Marginal Zone Lymphoma (MZL)
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Schnitzler SyndromeDr. Ray isAdvanced. Learn about Schnitzler Syndrome.
- Experienced
- Adult Soft Tissue SarcomaDr. Ray isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Ray isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Ray isExperienced. Learn about Anal Cancer.
- AnemiaDr. Ray isExperienced. Learn about Anemia.
- AngiosarcomaDr. Ray isExperienced. Learn about Angiosarcoma.